Načítá se...
Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
SIMPLE SUMMARY: Monoclonal antibodies represent a major therapeutic progress in multiple myeloma during the last decade. The use of antibodies as well as antibody drug conjugates has changed the treatment landscape rapidly. The intent of this paper is to summarize the current major results of monocl...
Uloženo v:
| Vydáno v: | Cancers (Basel) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8037134/ https://ncbi.nlm.nih.gov/pubmed/33805481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071571 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|